Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in
 children with short stature.
Inclusion Criteria:

 -  Children with short stature by growth hormone deficiency(GHD) or idiopathic short
 stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)

 -  Children who has official height record at least 6 months prior

 Exclusion Criteria:

 -  Children with Epiphyseal closure